CPT code 0963T denotes an anoscopically guided anal bulking injection: insertion of an anoscope and submucosal injection of a bulking agent to add tissue volume and improve anorectal function. The code covers a focused, minimally invasive procedure used in patients with fecal incontinence or other anorectal dysfunction where augmentation of the anal canal mucosa is indicated. Nationally, this code matters as clinicians and payers evaluate coverage, clinical indications, and site-of-service decisions for an emerging procedural option that can be performed in ambulatory surgical centers, hospital outpatient departments, or specialized procedure clinics.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find concise benchmarks for coverage and utilization where available, a review of clinical context and intended therapeutic goals, and issues that commonly affect reimbursement and coding practice such as site-of-service designation and procedure-level reporting. The summary highlights how the procedure fits into treatment pathways for anorectal dysfunction and what clinical documentation typically supports use of this code. Data not available in the input is noted where applicable.